FDA Alert: Lantus (insulin glargine)
Links shared publicly online about this topic.
- 1,926total visits
FDA Alert: Lantus (insulin glargine)
View full resource at drugs.com
Tags: Diabetes Type 1 Medication, Diabetes Type 2 Medication, Diabetes Medication, Insulin, FDA, Lantus
Most Recently Shared on July 2, 2009 at 11:15 pm By:
FDA Alert - FDA Reviewing Safety Data for Lantus (insulin glargine) - http://bit.ly/4pWcvU
Byetta Approved as Lantus Add-On :: Diabetes Self-Management
diabetesselfmanagement.com — “On October 19, the US Food and Drug Administration (FDA) approved the Type 2 diabetes medicine Byetta (exenatide) as an add-on treatment to Lantus (insulin glargine) in people who have not achieved blood glucose control with Lantus, diet, and exercise alone...” View full resource at diabetesselfmanagement.com
Most Recently Shared on November 4, 2011 at 3:28 pm By:
Diabetes Self-Mgmt Health Site
#diabetes Byetta has been approved by the FDA as an add-on to Lantus: http://t.co/bu1TmT5z
FDA determines no cancer risk associated with Lantus - MPR
empr.com — “At this time, the FDA has concluded that Lantus (insulin glargine [recombinant], from sanofi-aventis) does not increase the risk of cancer.” View full resource at empr.com
Most Recently Shared on January 25, 2011 at 4:23 pm By:
MPR News: FDA determines no cancer risk associated with Lantus: At this time, the FDA has concluded that Lantus ... http://bit.ly/ftLZYS
FDA determines no cancer risk associated with Lantus - ONA
oncologynurseadvisor.com — “At this time, the FDA has concluded that Lantus (insulin glargine [recombinant], from sanofi-aventis) does not increase the risk of cancer.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 25, 2011 at 3:48 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA determines no cancer risk associated with Lantus http://goo.gl/fb/26fJr
Endocrine News Now: FDA Completes Preliminary Safety Review of Lantus (insulin glargine)
endocrinenewsnow.org — “Endocrine News Now: FDA Completes Preliminary Safety Review of Lantus (insulin glargine)” View full resource at endocrinenewsnow.org
Most Recently Shared on January 18, 2011 at 4:01 pm By:
TheEndocrineSociety Medical Society
FDA Completes Preliminary Safety Review of Lantus http://www.endocrinenewsnow.org/2011/01/fda-completes-preliminary-safety-review.html
FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer
fda.gov — “[1-12-2011] The U.S. Food and Drug Administration (FDA) is updating the public about its ongoing safety review of Lantus (insulin glargine) and a possible increased risk of cancer.” View full resource at fda.gov
Most Recently Shared on January 13, 2011 at 2:49 pm By:
Scott Strumello Patient Expert
FDA Drug Safety Communication: Update to ongoing safety review of Lantus & possible risk of cancer http://t.co/WD685tf
FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer
fda.gov — “[1-12-2011] The U.S. Food and Drug Administration (FDA) is updating the public about its ongoing safety review of Lantus (insulin glargine) and a possible increased risk of cancer.” View full resource at fda.gov
Most Recently Shared on January 13, 2011 at 2:37 pm By:
NCI Cancer Bulletin Health News
FDA provides update on review of possible link between diabetes drug, cancer risk: http://bit.ly/hVDraB
FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer - Drugs.com MedNews
drugs.com — “Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary References Safety Announcement 1-12-201” View full resource at drugs.com
Most Recently Shared on January 13, 2011 at 1:11 pm By:
Drugs and Devices OW OW Health
FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible r... http://bit.ly/ewUL1F #drug
Medical News: FDA Still Uncertain About Lantus Cancer Risk - in Endocrinology, Diabetes from MedPage Today
medpagetoday.com — “Eighteen months after starting a probe of potential cancer risks associated with insulin glargine (Lantus), the FDA still hasn't decided whether the concern is justified, the agency said.” View full resource at medpagetoday.com
Most Recently Shared on January 12, 2011 at 10:36 pm By:
FDA Still Uncertain About Lantus Cancer Risk http://bit.ly/exWVO3
FDA Tells Patients to Stick With Diabetes Drug Linked to Cancer - Health News - Health.com
news.health.com — “Despite recent studies suggesting that the injected diabetes drug Lantus (insulin glargine) might boost cancer risk, the U.S. Food and Drug Administration on Wednesday urged patients who are on the medication to continue using it.” View full resource at news.health.com
Most Recently Shared on July 3, 2009 at 12:47 am By:
FDA Tells Patients to Stick With Diabetes Drug Linked to Cancer: Despite recent studies suggesting that the inje.. http://tinyurl.com/lhhsrw
Medical News: FDA Reviewing Safety Data for Insulin Glargine - in Cardiovascular, Diabetes from MedPage Today
medpagetoday.com — “WASHINGTON -- In light of four recently published studies showing a link between insulin glargine (Lantus) and cancer, the FDA announced it is reviewing safety for the drug, but urged diabetic patien” View full resource at medpagetoday.com
Most Recently Shared on July 1, 2009 at 9:56 pm By:
CARDIOLOGY• FDA Reviewing Safety Data for Insulin Glargine http://tinyurl.com/ms5lx2
Early Communication About Safety of Lantus (insulin glargine)
fda.gov — “Fda is aware of four recently-published observational studies that looked at the use of lantus (insulin glargine) and possible risk for cancer in patients with diabetes.” View full resource at fda.gov
Most Recently Shared on July 1, 2009 at 7:45 pm By:
FDA Early Communication About Safety of Lantus (insulin glargine) http://bit.ly/10bFXc
Lantus and Cancer: Further Study Needed :: Diabetes Self-Management
diabetesselfmanagement.com — “Late last week, results from several european studies showing a possible link between lantus (insulin glargine) and cancer were published online in the journal diabetologia. health agencies such as the u.s. food and drug administration (fda) and the international diabetes federation (idf) have been swift in their response to the release of this information, indicating that the studies are not conclusive and that people with diabetes should not stop taking lantus without speaking to their doctors” View full resource at diabetesselfmanagement.com
Most Recently Shared on July 1, 2009 at 7:23 pm By:
Diabetes Self-Mgmt Health Site
#diabetes New Blog post by Diane Fennell: Lantus and Cancer: Further Study Needed http://bit.ly/3ZXIL
Advertisement
